
Feature|Articles|May 12, 2026
- May/June 2026
- Volume 42
- Issue 02
Chronic skin conditions linked to bullying, depression, and suicide risk in children, adolescents
Author(s)Morgan Ebert, Executive Editor
Fact checked by: Benjamin P. Saylor, Ron Panarotti
Chronic pediatric skin disorders cause significant stigma, bullying, depression, and suicide risk—conditions often underrecognized and undertreated by physicians.
Advertisement
Advertisement
Pediatric patients with chronic skin diseases—including acne, atopic dermatitis (AD), and psoriasis—face significant and frequently underappreciated risks to their mental health and social well-being, according to findings from several recent studies examining quality of life, stigmatization, and psychiatric comorbidities in this population.1-5
Related to this article

Caregivers reported itch, symptom, and QOL gains with roflumilast cream 0.05% in infants with AD; an FDA decision is due February 2027.

Full OptIMMize-1 results show high skin clearance rates with risankizumab in children and teens with psoriasis, sustained through 52 weeks.

Emily Becker, MD, discusses the role of AhR agonists, skin barrier function, and steroid-free treatment options for pediatric atopic dermatitis.

Post hoc data show cariprazine improved both manic and depressive symptoms through 52 weeks in youth aged 10 to 17 years with bipolar I disorder.

A meta-analysis of 52 studies links NO2, SO2, and particulate matter to more pediatric atopic dermatitis visits and higher prevalence.

Learn how to distinguish true ADHD from anxiety, trauma, sleep issues, or substance use by tracing symptoms back to childhood across settings and impairment.

NHIS data show the share of US children aged 5 to 17 years ever diagnosed with ADHD climbed from 9.9% in 2019 to 13.8% in 2025.
Advertisement
Advertisement

